Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.
about
"Trivalent influenza vaccination of healthy adults 3 years after the onset of swine-origin H1N1 pandemic: restricted immunogenicity of the new A/H1N1v constituent?".Immunologic Effects of the Renin-Angiotensin System.Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis?
P2860
Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.
@en
Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.
@nl
type
label
Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.
@en
Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.
@nl
prefLabel
Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.
@en
Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.
@nl
P2093
P2860
P1476
Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety
@en
P2093
Amir S Talebian
Hassan Argani
Keivan G Moghaddam
Maryam Keshtkar-Jahromi
Marzieh Keshtkar-Jahromi
Sasan Tavana
Seyed-Mostafa Razavi
Sharareh Gholamin
Talat M Azad
P2860
P304
P356
10.1111/J.1750-2659.2011.00290.X
P577
2011-09-28T00:00:00Z